Polymerase Chain Reaction Market Analysis | CMI - PowerPoint PPT Presentation

View by Category
About This Presentation

Polymerase Chain Reaction Market Analysis | CMI


Read here the latest updates on the Polymerase Chain Reaction Market Analysis published by CMI team – PowerPoint PPT presentation

Number of Views:5
Date added: 7 October 2020
Slides: 12
Provided by: Shweta2707
Category: Other


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Polymerase Chain Reaction Market Analysis | CMI

  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//www.coherentmarketinsights.com/
  • COVID-19 Impact Tracker

  • Polymerase Chain Reaction Market, by Product Type
    (Instrument (Real Time PCR, Digital PCR, Others)
    Reagents and Consumables)), by End User (Clinical
    Diagnostics, Academic and Research Laboratories,
    Forensic Laboratories, Others) - Global Industry
    Insights, and Forecast to 2025
  • The global polymerase chain reaction market was
    valued at US 3.7 billion in 2017 and is expected
    to witness a CAGR of 8.8 over the forecast
    period (2017 2025).

Global Polymerase Chain Reaction Market Share
(), By Product Type
Market Drivers
  • Increasing Numbers of Product Launches and
    Collaborations in Polymerase Chain Reaction are
    expected to Drive Growth of the Polymerase Chain
    Reaction Market
  • Key players in the polymerase chain reaction
    market are engaged in launching advanced and
    novel PCR instruments and consumables, which will
    allows rapid and easy nucleic acid amplification.
    For instance, in October 2017, Diatech
    Pharmacogenetics srl launched easyPGX a ready to
    use in-vitro diagnostic real-time PCR product
    line and Helix a polymerase chain reaction kit
    for the extraction of circulating free DNA from
    plasma. In September 2015, Bio-Rad Laboratories
    launched droplet digital PCR (ddPCR) Supermix for
    Residual DNA Quantification. The new supermix
    designed to use with Bio-Rads Droplet Digital
    PCR Systems offers highly precise and sensitive
    method for DNA measurement. In November 2014,
    Chai Biotechnologies Inc. introduced Open qPCR
    Real-Time PCR Thermocycler. The new instrument is
    designed to use for genetic genotyping, pathogen
    detection, and relative DNA quantification.
    Moreover, in April 2014, Bio-Rad Laboratories
    launched Precision Blue Real-Time PCR Dye. The
    new Precision Blue dye is compatible with
    Bio-Rads universal qPCR supermixes, and can be
    used with all Bio-Rads CFx real time PCR
  • Furthermore, key players are involved in several
    collaborations to expand their geographical
    horizon and increase patient reach. For instance,
    in March 2018, Akonni Biosystems Inc. and a
    Chinese in-vitro diagnostics company Righton
    signed a commercial agreement, which enables
    Righton to sell Akonni's TruDiagnosis and TruTip
    Nucleic Acid Purification Kits in China.
    TruDiagnosis is based on proprietary on-slide PCR
    and gel-drop microarray technology. In January
    2018, Thermo Fisher Scientific and Illumina, Inc.
    signed a commercial agreement. Under the
    agreement, Thermo Fisher will provide Ion
    AmpliSeq technology to Illumina for research
    purpose. Moreover, in December 2017, Genome
    Diagnostics (GenDx) signed a global reseller
    agreement with Thermo Fisher Scientific,
    assigning GenDx as a non-exclusive reseller of
    Thermo Fishers QuantStudio real-time PCR
    instrument. Under the agreement, GenDx will
    market the QuantStudio real-time PCR in the
    Netherlands and other European countries. Thus,
    significant organic and inorganic growth
    strategies by various key players is driving
    growth of the polymerase chain reaction market.

  • Increasing Prevalence of Chronic and Infectious
    Disease are Driving Growth of Polymerase Chain
    Reaction Market
  • Polymerase chain reaction is increasingly used in
    clinical diagnosis of infectious disease, nucleic
    acid amplification, paternity testing, DNA
    fingerprinting, detection and diagnosis of
    infectious disease, quality control, and
    personalized medicine. For instance, according to
    the Centers for Disease Control and Prevention
    (CDC), around 5,251 deaths due to the influenza
    infection were registered in 2015, in U.S.
    According to the World Health Organization (WHO),
    in 2015, around 32,000 estimated deaths were
    reported from tuberculosis and around 3, 23,000
    new cases of TB cases were registered in the
    European region. According to the National
    Ambulatory Medical Care Survey 2015 data
    findings, 16.8 million visits to physician
    offices for infectious and parasitic diseases
    were registered in the U.S. According to the
    World Health Organization (WHO), 2016, around
    555,318 new cases of cancer were reported in
    2012, in the Middle East Region. The region is
    expected to witness the highest relative increase
    of cancer cases among the regions in the world
    accounting to 961,098 cases by 2030. Moreover,
    according to the Cancer Atlas, 2012, about 1.1
    million new cancer cases and 600,000 cancer
    deaths occurred annually in Latin America and the
    Caribbean, where lung cancer is the leading cause
    of cancer death for both genders combined in the

Market Restraints
  • However, advances in research are leading to
    generation of various alternative nucleic acid
    amplification methods, which may hinder growth of
    the polymerase chain reaction market over the
    forecasted period. Such alternative methods of
    nucleic acid amplification includes loop
    medicated isothermal amplification, nucleic acid
    sequence based amplification, strand displacement
    amplification, and multiple displacement
    amplification. These methods offers better
    applicability and sensitivity in nucleic acid
    amplification, where PCR shows limitations such
    as contamination, sensitivity to certain classes
    of contaminants and inhibitors, and requirement
    of thermal cycling.
  • Key players in the polymerase chain reaction are
    engaged in offering PCR-free nucleic acid
    detection methods. For instance, in March 2018,
    Quanterix Corporation and DestiNA Genomics
    collaborated to develop PCR-free microRNA
    detection method with high-specificity and
    ultra-sensitivity, thereby enhancing RNA
    biomarker detection.

Key Players
  • Key players operating in polymerase chain
    reaction market include F. Hoffmann-La Roche Ltd,
    Bio-Rad Laboratories, Inc., Thermo Fisher
    Scientific Inc., Agilent Technologies, Inc.,
    bioMérieux, S.A., Enzo Life Science, Inc., Abbott
    Laboratories, Takara Bio Inc., Becton, Dickinson
    and Company, and Danaher Corporation.

  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Reference https//www.coherentmarketinsights.com

About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
  • Phone 1-206-701-6702
  • Email sales_at_coherentmarketinsights.com

  • Thank You!
  • Kindly follow CMI Social Media Profiles
    for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//www.coherentmarketinsights.com/
About PowerShow.com